Adial Pharmaceuticals, Inc. WT EXP 073123

Adial Pharmaceuticals, Inc. WT EXP 073123

ADILW
Adial Pharmaceuticals, Inc. WT EXP 073123US flagNASDAQ Capital Market
0.00
USD
+0.00
(-57.14%)
Mar 31Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
None
Address
DE United States of America
IPO Date
Jul 27, 2018
Similar Companies
Business

Company News

  • Adial Pharmaceuticals Receives Notice of Allowance of Additional Patent for the Treatment of Alcohol Use Disorder with AD04 in Patients Identified Using a Molecular Genetic Biomarker